Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Igm Biosciences Inc
(NQ:
IGMS
)
15.41
+0.51 (+3.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Igm Biosciences Inc
< Previous
1
2
3
4
5
6
Next >
IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
June 22, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Announces Proposed Public Offering and Concurrent Private Placement
June 21, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for IGM Biosciences
June 06, 2023
Via
Benzinga
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday
June 05, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Analyst Expectations for IGM Biosciences's Future
May 15, 2023
Via
Benzinga
Recap: IGM Biosciences Q1 Earnings
May 12, 2023
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
June 02, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Where IGM Biosciences Stands With Analysts
April 03, 2023
Via
Benzinga
Earnings Preview For IGM Biosciences
March 29, 2023
Via
Benzinga
IGM Biosciences to Present at the Jefferies Healthcare Conference
June 01, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
May 31, 2023
Imvotamab, a CD20 x CD3 bispecific monoclonal antibody, offers potential for deeper B cell depletion than currently approved therapies
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update
May 30, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 12, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
May 04, 2023
Via
Benzinga
IGM Biosciences to Present at Two Upcoming Investor Conferences
May 02, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
April 19, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023
April 13, 2023
Presentations highlight data from across all oncology pipeline programs
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday
March 31, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023
March 27, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
February 02, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
January 17, 2023
– Targeted IL-15/IL-15R IgM antibody to be evaluated for safety and pharmacodynamic effects –
From
IGM Biosciences, Inc.
Via
GlobeNewswire
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday
January 12, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 12, 2023
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...
Via
Benzinga
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
January 09, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
IGM Biosciences, Inc.
Via
GlobeNewswire
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
December 11, 2022
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations
From
IGM Biosciences, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.